MARONGIU, Andrea
MARONGIU, Andrea
MEDICINA, CHIRURGIA E FARMACIA
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis
2022-01-01 Di Bella, M. P.; Frau, C.; Pintus, T.; Lopes, M.; Bagella, C.; Marongiu, A.; Spanu, A.; Madeddu, G.; Solla, P.; Nuvoli, S.
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary?
2022-01-01 Nuvoli, Susanna; Palumbo, Barbara; Marongiu, Andrea; Bianconi, Francesco; Spanu, Angela
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma
2020-01-01 Nuvoli, S.; Marongiu, A.; Gelo, I.; Mele, L.; Rondini, M.; Stazza, M. L.; Madeddu, G.; Spanu, A.
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC).
2021-01-01 Nuvoli, S.; Marongiu, A.; Gelo, I.; Luciana, M.; Stazza, M. L.; Rondini, M.; Spanu, A.; Madeddu., G.
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up
2019-01-01 Marongiu, Andrea; Nuvoli, Susanna Maria Francesca; Gelo, Ilaria; Mele, Luciana; Piras, Bastiana; Stazza, Maria Lina; Galassi, Sarah; Madeddu, Giuseppe.; Spanu, Angela
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation
2022-01-01 Marongiu, A.; Nuvoli, S.; Solinas, P.; Rondini, M.; Papaleo, A.; Spanu, A.; Madeddu, G.
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes
2022-01-01 Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study
2024-01-01 Nuvoli, S.; Fiorillo, E.; Mura, A.; Piras, M. R.; Sanna, C.; Marongiu, A.; Marongiu, M.; Lobina, M.; Orrù, V.; Piras, M. G.; Madeddu, G.; Spanu, A.; Cucca., F.
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage.
2024-01-01 Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna.
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease
2022-01-01 Marongiu, Andrea; Nuvoli, Susanna; De Vito, Andrea; Rondini, Maria; Spanu, Angela; Madeddu, Giuseppe
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy
2022-01-01 Frantellizzi, V.; Corica, F.; Rondini, M.; De Feo, M. S.; Stazza, M. L.; Conte, M.; Marongiu, A.; Nuvoli, S.; Farcomeni, A.; De Vincentis, G.; Spanu, A.
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG
2022-01-01 De Angelis, C.; De Feo, M. S.; Di Rocco, A.; Rondini, M.; Lazzarato, A.; Marongiu, A.; Frantellizzi, V.; Spanu, A.; Nuvoli, S.; De Vincentis, G.
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases
2022-01-01 Papaleo, A.; Rondini, M.; Chessa, F.; De Vito, A.; Marongiu, A.; Fadda, C.; Medda, E.; Vargiu, S.; Nuvoli, S.; Spanu, A.
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance
2022-01-01 Lazzarato, A.; Sanna, C.; Galleri, P.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.; Nuvoli, S.
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia
2022-01-01 Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S.
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders
2024-01-01 Marongiu, A.; Galleri, P.; Sanna, C.; Fadda, C.; Di Bella, M.; Medde, E.; Vargiu, S.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli., S.
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review
2022-01-01 De Feo, Maria Silvia; Sidrak, Marko Magdi Abdou; Conte, Miriam; Frantellizzi, Viviana; Marongiu, Andrea; De Cristofaro, Flaminia; Nuvoli, Susanna; Spanu, Angela; De Vincentis, Giuseppe
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
2024-01-01 Putzu, Carlo; Serra, Riccardo; Campus, Rachele; Fadda, Giovanni Maria; Sini, Claudio; Marongiu, Andrea; Ginesu, Giorgio Carlo; Fois, Alessandro Giuseppe; Palmieri, Giuseppe; Zinellu, Angelo; Cossu, Antonio; Paliogiannis, Panagiotis
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms
2022-01-01 Nuvoli, S.; Lazzarato, A.; Carlo, S.; Galleri, P.; Marongiu, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers
2022-01-01 Nuvoli, S.; Bianconi, F.; Rondini, M.; Lazzarato, A.; Marongiu, A.; Fravolini, M. L.; Cascianelli, S.; Amici, S.; Filippi, L.; Spanu, A.; Palumbo, B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis | 1-gen-2022 | Di Bella, M. P.; Frau, C.; Pintus, T.; Lopes, M.; Bagella, C.; Marongiu, A.; Spanu, A.; Madeddu, G.; Solla, P.; Nuvoli, S. | |
| 123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? | 1-gen-2022 | Nuvoli, Susanna; Palumbo, Barbara; Marongiu, Andrea; Bianconi, Francesco; Spanu, Angela | |
| 131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma | 1-gen-2020 | Nuvoli, S.; Marongiu, A.; Gelo, I.; Mele, L.; Rondini, M.; Stazza, M. L.; Madeddu, G.; Spanu, A. | |
| 131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). | 1-gen-2021 | Nuvoli, S.; Marongiu, A.; Gelo, I.; Luciana, M.; Stazza, M. L.; Rondini, M.; Spanu, A.; Madeddu., G. | |
| 131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up | 1-gen-2019 | Marongiu, Andrea; Nuvoli, Susanna Maria Francesca; Gelo, Ilaria; Mele, Luciana; Piras, Bastiana; Stazza, Maria Lina; Galassi, Sarah; Madeddu, Giuseppe.; Spanu, Angela | |
| 131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation | 1-gen-2022 | Marongiu, A.; Nuvoli, S.; Solinas, P.; Rondini, M.; Papaleo, A.; Spanu, A.; Madeddu, G. | |
| 18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes | 1-gen-2022 | Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G. | |
| 18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study | 1-gen-2024 | Nuvoli, S.; Fiorillo, E.; Mura, A.; Piras, M. R.; Sanna, C.; Marongiu, A.; Marongiu, M.; Lobina, M.; Orrù, V.; Piras, M. G.; Madeddu, G.; Spanu, A.; Cucca., F. | |
| 18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. | 1-gen-2024 | Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna. | |
| A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease | 1-gen-2022 | Marongiu, Andrea; Nuvoli, Susanna; De Vito, Andrea; Rondini, Maria; Spanu, Angela; Madeddu, Giuseppe | |
| A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy | 1-gen-2022 | Frantellizzi, V.; Corica, F.; Rondini, M.; De Feo, M. S.; Stazza, M. L.; Conte, M.; Marongiu, A.; Nuvoli, S.; Farcomeni, A.; De Vincentis, G.; Spanu, A. | |
| A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG | 1-gen-2022 | De Angelis, C.; De Feo, M. S.; Di Rocco, A.; Rondini, M.; Lazzarato, A.; Marongiu, A.; Frantellizzi, V.; Spanu, A.; Nuvoli, S.; De Vincentis, G. | |
| Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases | 1-gen-2022 | Papaleo, A.; Rondini, M.; Chessa, F.; De Vito, A.; Marongiu, A.; Fadda, C.; Medda, E.; Vargiu, S.; Nuvoli, S.; Spanu, A. | |
| Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance | 1-gen-2022 | Lazzarato, A.; Sanna, C.; Galleri, P.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.; Nuvoli, S. | |
| Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia | 1-gen-2022 | Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S. | |
| Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders | 1-gen-2024 | Marongiu, A.; Galleri, P.; Sanna, C.; Fadda, C.; Di Bella, M.; Medde, E.; Vargiu, S.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli., S. | |
| Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review | 1-gen-2022 | De Feo, Maria Silvia; Sidrak, Marko Magdi Abdou; Conte, Miriam; Frantellizzi, Viviana; Marongiu, Andrea; De Cristofaro, Flaminia; Nuvoli, Susanna; Spanu, Angela; De Vincentis, Giuseppe | |
| Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy | 1-gen-2024 | Putzu, Carlo; Serra, Riccardo; Campus, Rachele; Fadda, Giovanni Maria; Sini, Claudio; Marongiu, Andrea; Ginesu, Giorgio Carlo; Fois, Alessandro Giuseppe; Palmieri, Giuseppe; Zinellu, Angelo; Cossu, Antonio; Paliogiannis, Panagiotis | |
| Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms | 1-gen-2022 | Nuvoli, S.; Lazzarato, A.; Carlo, S.; Galleri, P.; Marongiu, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G. | |
| Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers | 1-gen-2022 | Nuvoli, S.; Bianconi, F.; Rondini, M.; Lazzarato, A.; Marongiu, A.; Fravolini, M. L.; Cascianelli, S.; Amici, S.; Filippi, L.; Spanu, A.; Palumbo, B. |